Veraxa Biotech Holding AG (VRXA) Total Liabilities (2024 - 2025)
Veraxa Biotech Holding AG (VRXA) posted quarterly Total Liabilities of $120.8 million for Q4 2025, up 97.1% year-over-year from $61.3 million in Q4 2024, and up 97.1% quarter-over-quarter from $61.3 million in Q4 2024.
Veraxa Biotech Holding AG (VRXA) Total Liabilities (2024 - 2025) Analysis & Trends
Veraxa Biotech Holding AG (VRXA) has reported Total Liabilities for 2 consecutive years, with $120.8 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Total Liabilities rose 97.1% year-over-year to $120.8 million; the TTM figure through Dec 2025 stood at $120.8 million (up 97.1% YoY), while the FY2025 annual figure was $120.8 million, up 97.1% from the prior year.
- Total Liabilities grew to $120.8 million in Q4 2025 per VRXA's latest filing, from $61.3 million in the prior quarter.
- Across five years, Total Liabilities topped out at $120.8 million in Q4 2025 and bottomed at $61.3 million in Q4 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 120.85 Mn |
| Dec 31, 2024 | 61.31 Mn |